Vivanza Biosciences Ltd

Statement of profit and loss

Vivanza Biosciences Ltd has not filed a concall transcript in the last 4 quarters.

• 20 Aug 2026

  Filing

  Newspaper Publication

• 19 Aug 2026

  Filing

  Reg. 34 (1) Annual Report.

• 19 Aug 2026

  Filing

  Notice Of The 44Th Annual General Meeting (''''AGM'''') And Annual Report Of The Company For The Financial Year 2025-26

• 17 Aug 2026

  Board meeting

  Board Meeting Outcome for Outcome Of Board Meeting Held On 17.08.2026

• 12 Aug 2026

  Board meeting

  Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29(1)(A) And Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

• 08 Aug 2026

  Filing

  Non Applicability Of Statement Of Deviation Or Variation Under Regulation 32 Of SEBI LODR Regulations, 2015

• 08 Aug 2026

  Filing

  Newspaper Publication

• 07 Aug 2026

  Results

  Outcome Of Board Of Directors Meeting Of Vivanza Biosciences Limited ('The Company')

  Appears 2 times in the recent filings shown; listed once.

• 07 Aug 2026

  Board meeting

  Board Meeting Outcome for Outcome Of Board Meeting To Consider And Approve Unaudited Financial Results (Standalone And Consolidated) For Quarter Ended 30Th June 2026

• 31 Jul 2026

  Board meeting

  Update on board meeting

• 28 Jul 2026

  Board meeting

  Board Meeting Intimation for The Consideration And Approval Of The Quarterly Financial Result Ended On 30Th June, 2026.

• 14 Jul 2026

  Filing

  Declaration Pursuant To Regulation 33(3)(D) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.